Scholtz & Company, LLC
- SEC CIK
- 0001606134
- Latest filing
- Aug 11, 2026
ELV holding history
Elevance Health, Inc. in every 13F filed by Scholtz & Company, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ELV overviewAll 13F holders of ELVFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −4,827−100.0% | Sold out | Holders |
| Q3 2024 | 4,827 | $2.51M | 1.2% | +30+0.6% | Added | Holders |
| Q2 2024 | 4,797 | $2.60M | 1.1% | −74−1.5% | Reduced | Holders |
| Q1 2024 | 4,871 | $2.53M | 1.1% | −1,760−26.5% | Reduced | Holders |
| Q4 2023 | 6,631 | $3.13M | 1.5% | −793−10.7% | Reduced | Holders |
| Q3 2023 | 7,424 | $3.23M | 2.1% | −1,281−14.7% | Reduced | Holders |
| Q2 2023 | 8,705 | $3.87M | 2.4% | −84−1.0% | Reduced | Holders |
| Q1 2023 | 8,789 | $4.04M | 2.9% | −198−2.2% | Reduced | Holders |
| Q4 2022 | 8,987 | $4.61M | 3.3% | −76−0.8% | Reduced | Holders |
| Q3 2022 | 9,063 | $4.45M | 3.2% | +491+5.7% | Added | Holders |
| Q2 2022 | 8,572 | $4.14M | 2.5% | +8,572 | New | Holders |